Clarus Ventures

Summary

Clarus Ventures appeared to be the VC, which was created in 2005. The company was established in North America in United States. The main office of represented VC is situated in the Cambridge.

The fund is constantly included in 2-6 investment rounds annually. The higher amount of exits for fund were in 2013. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Clarus Ventures performs on 1 percentage points more the average number of lead investments. The high activity for fund was in 2010. Considering the real fund results, this VC is 21 percentage points more often commits exit comparing to other organizations.

The fund was created by David Field. The overall number of key employees were 7.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Clarus Ventures, startups are often financed by SV Health Investors, New Leaf Venture Partners, 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are 5AM Ventures, New Leaf Venture Partners, OrbiMed. In the next rounds fund is usually obtained by New Leaf Venture Partners, 5AM Ventures, SV Health Investors.

Among the various public portfolio startups of the fund, we may underline Annexon Biosciences, TetraLogic Pharmaceuticals, Aerovance For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Medical, Therapeutics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.